$329.30 Million in Sales Expected for ICU Medical, Incorporated (ICUI) This Quarter

Brokerages forecast that ICU Medical, Incorporated (NASDAQ:ICUI) will report sales of $329.30 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for ICU Medical’s earnings, with the highest sales estimate coming in at $329.60 million and the lowest estimate coming in at $329.00 million. ICU Medical reported sales of $95.68 million during the same quarter last year, which indicates a positive year-over-year growth rate of 244.2%. The company is expected to announce its next earnings results on Wednesday, March 7th.

On average, analysts expect that ICU Medical will report full year sales of $329.30 million for the current fiscal year, with estimates ranging from $1.24 billion to $1.25 billion. For the next year, analysts expect that the business will post sales of $1.34 billion per share. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for ICU Medical.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, November 9th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.35. The firm had revenue of $343.20 million during the quarter, compared to analysts’ expectations of $328.56 million. ICU Medical had a return on equity of 4.81% and a net margin of 2.79%. The business’s revenue was up 253.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.35 EPS.

ICUI has been the subject of a number of research analyst reports. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $232.00 target price for the company in a research report on Thursday, November 16th. KeyCorp assumed coverage on ICU Medical in a research note on Tuesday, October 17th. They set a “sector weight” rating for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $232.00.

Shares of ICU Medical (ICUI) opened at $229.35 on Thursday. The stock has a market capitalization of $4,607.88, a PE ratio of 148.93, a P/E/G ratio of 2.53 and a beta of 0.36. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.65 and a quick ratio of 3.01. ICU Medical has a 1 year low of $131.35 and a 1 year high of $233.20.

In other ICU Medical news, Director George A. Lopez sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $205.83, for a total transaction of $1,029,150.00. Following the completion of the sale, the director now directly owns 573,916 shares of the company’s stock, valued at approximately $118,129,130.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Chairman Vivek Jain sold 97,795 shares of the company’s stock in a transaction that occurred on Friday, October 20th. The shares were sold at an average price of $190.00, for a total value of $18,581,050.00. Following the sale, the chairman now directly owns 67,680 shares of the company’s stock, valued at $12,859,200. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 129,419 shares of company stock valued at $25,454,700. 13.60% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Ameritas Investment Partners Inc. raised its stake in ICU Medical by 4.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,321 shares of the medical instruments supplier’s stock valued at $228,000 after acquiring an additional 51 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock valued at $122,000 after acquiring an additional 66 shares during the last quarter. Amalgamated Bank raised its stake in ICU Medical by 5.3% during the 2nd quarter. Amalgamated Bank now owns 2,063 shares of the medical instruments supplier’s stock valued at $356,000 after acquiring an additional 104 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of ICU Medical by 1.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,468 shares of the medical instruments supplier’s stock worth $1,979,000 after buying an additional 146 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in shares of ICU Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after buying an additional 157 shares in the last quarter. 78.13% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “$329.30 Million in Sales Expected for ICU Medical, Incorporated (ICUI) This Quarter” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/18/329-30-million-in-sales-expected-for-icu-medical-incorporated-icui-this-quarter-2.html.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Get a free copy of the Zacks research report on ICU Medical (ICUI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply